Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Paratek Pharmaceuticals, Inc. (PRTK)

Pharmaceutical Preparations

https://www.paratekpharma.com

Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's medical research is based on tetracycline chemistry and biology to create two antibacterials: omadacycline and sarecycline. NUZYRA (Omadacycline) is an antibacterial for skin infections and treatment of community-acquired bacterial pneumonia. SEYSARA (Sarecycline) is designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals is also involved in research to treat multiple sclerosis, spinal muscular atrophy, and systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/10/2006

Market Cap

127,828,952

Shares Outstanding

57,320,000

Weighted SO

57,322,358

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

SELB --.--%

CRVS --.--%

IMMP --.--%

ICVX --.--%

LYRA --.--%

EQ --.--%

HOOK --.--%

LIAN --.--%

Beta

1.6978

Last Div

31.9730

Range

1.29-3.65

Chg

0.0400

Avg Vol

599679

Mkt Cap

127828952

Exch

NASDAQ

Country

US

Phone

617 807 6600

DCF Diff

1.6593

DCF

3.7493

Div Yield

0.0000

P/S

0.9137

EV Multiple

-12.6876

P/FV

-0.6344

Div Yield %

0.0000

P/E

-3.0521

PEG

-0.7447

Payout

0.0000

Current Ratio

0.5193

Quick Ratio

0.4205

Cash Ratio

0.2107

DSO

110.9139

DIO

199.0893

Op Cycle

310.0032

DPO

51.4775

CCC

258.5257

Gross Margin

0.8504

Op Margin

-0.2005

Pretax Margin

-0.2980

Net Margin

-0.2992

Eff Tax Rate

-0.0041

ROA

-0.2871

ROE

0.2236

ROCE

0.4937

NI/EBT

1.0041

EBT/EBIT

1.4859

EBIT/Rev

-0.2005

Debt Ratio

1.7817

D/E

-1.2900

LT Debt/Cap

-0.9059

Total Debt/Cap

4.4486

Int Coverage

-1.9589

CF/Debt

-0.0416

Equity Multi

-0.7240

Rec Turnover

3.2908

Pay Turnover

7.0905

Inv Turnover

1.8333

FA Turnover

63.6185

Asset Turnover

0.9596

OCF/Share

-0.1885

FCF/Share

-0.1897

Cash/Share

0.7452

OCF/Sales

-0.0772

FCF/OCF

1.0063

CF Coverage

-0.0416

ST Coverage

-0.0658

CapEx Coverage

-158.8088

Div&CapEx Cov

-158.8088

P/BV

-0.6344

P/B

-0.6344

P/S

0.9137

P/E

-3.0521

P/FCF

-11.7630

P/OCF

-11.8288

P/CF

-11.8288

PEG

-0.7447

P/S

0.9137

EV Multiple

-12.6876

P/FV

-0.6344

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.06 10/31/2014 10/14/2014 10/24/2014 11/30/-0001
0.67 10/22/2014 11/30/-0001 11/30/-0001 11/30/-0001
1.33 06/04/2014 05/14/2014 05/26/2014 11/30/-0001
1.33 05/21/2014 11/30/-0001 05/26/2014 06/03/2014